ion channels

Home/Tag: ion channels

Metrion Biosciences Appoints Mark Keogh as Non-Executive Director

2021-04-19T08:01:56+00:00

Metrion Biosciences appoints Mark Keogh as Non-Executive Director Appointment strengthens the financial and corporate experience of Metrion’s Board in support of the Company’s planned international growth Cambridge, UK, 19 April 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Mark Keogh as a [...]

Metrion Biosciences Appoints Mark Keogh as Non-Executive Director2021-04-19T08:01:56+00:00

Metrion Biosciences closes £2.7m new equity financing

2021-04-06T07:59:45+00:00

Metrion Biosciences closes £2.7m new equity financing • Financing led by Gresham House Ventures • Funds to be used to enhance Metrion’s Cambridge, UK ion channel drug discovery laboratories and capabilities and expand its presence in the USA • Maya Ward, Associate Director, Gresham House Ventures, appointed to Metrion Board of Directors Cambridge, UK, [...]

Metrion Biosciences closes £2.7m new equity financing2021-04-06T07:59:45+00:00

The Drug Discovery for Ion Channels XXII Satellite Meeting

2021-03-26T20:03:12+00:00

The Drug Discovery for Ion Channels XXII Satellite Meeting A global pandemic wasn’t going to stand in our way Nothing was going to prevent this annual gathering of ion channel enthusiasts and drug discovery professionals from taking place. Planning got underway in late 2020 to facilitate the virtual organisation and smooth running of the [...]

The Drug Discovery for Ion Channels XXII Satellite Meeting2021-03-26T20:03:12+00:00

Biophysical Society Annual Meeting 2021

2020-11-17T13:54:50+00:00

Metrion Biosciences will be attending the Biophysical Society Annual Meeting to be hosted virtually from 22nd to 26th February 2021. Metrion will be presenting two posters and taking part in the virtual exhibition at the event. Please keep an eye on our website for more information as the event date approaches. If you would like [...]

Biophysical Society Annual Meeting 20212020-11-17T13:54:50+00:00

Ion Channels in Drug Discovery XXII Virtual Meeting

2021-02-12T08:38:19+00:00

Metrion is co-organising and attending the 'Drug Discovery for Ion Channels XXII' Virtual satellite meeting. This is a collaborative meeting, organised alongside partners Nanion, Sophion, Fluxion and SB Drug Discovery. The final line-up of Speakers is given below and can also be found here. The event will start at 8AM PST / 4PM GMT/ 5PM [...]

Ion Channels in Drug Discovery XXII Virtual Meeting2021-02-12T08:38:19+00:00

Metrion Biosciences appoints John Montana as Non-Executive Director

2021-02-09T09:05:37+00:00

Metrion Biosciences appoints John Montana as Non-Executive Director Expansion of the Board of Directors will support the company’s further growth as an ion channels focused drug discovery CRO Cambridge, UK, 09 February 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of John Montana, [...]

Metrion Biosciences appoints John Montana as Non-Executive Director2021-02-09T09:05:37+00:00

Metrion Biosciences and Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration

2021-02-01T08:45:23+00:00

Metrion Biosciences and Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration • Ion channels represent a large but under-exploited class of drug targets beyond G protein-coupled receptors (GPCRs) • Collaboration combines Sosei Heptares’ leading structure-based drug design platform with Metrion Biosciences’ ion channel expertise • Joint [...]

Metrion Biosciences and Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration2021-02-01T08:45:23+00:00

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration

2021-01-18T09:56:07+00:00

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge and London, UK, 18 January 2021: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent [...]

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration2021-01-18T09:56:07+00:00

SARS-CoV-2 Drug Discovery: Targeting Viral Ion Channels

2021-01-07T16:10:40+00:00

Image above: As well as the spike (S) protein which binds to human cells, there are other transmembrane proteins including the M class and the viroporin envelope protein (E) ion channel. Ion channels are well validated drug discovery targets based on their widespread distribution in the human body and involvement in many critical [...]

SARS-CoV-2 Drug Discovery: Targeting Viral Ion Channels2021-01-07T16:10:40+00:00

Charlotte’s Patch Clamp Journey So Far…

2020-11-10T14:51:46+00:00

Metrion Scientist Dr Charlotte Hill explains how she first discovered the wonderful world of patch clamp electrophysiology and how she came to write the chapter "An Introduction to Patch Clamp Recording" alongside Dr Gary Stephens. This chapter is featured within the book "An Introduction to Patch Clamp Recording" edited by Dr Damian Bell and [...]

Charlotte’s Patch Clamp Journey So Far…2020-11-10T14:51:46+00:00
Go to Top